Yash B Shah, Cassra B Clark, Andrew Shumaker, Andrew A Denisenko, Samuel Alfonsi, Zachary Prebay, Joseph Schultz, Vasil Mico, Vishal Swaminathan, Roy Wang, James R Mark, Edouard J Trabulsi, Costas D Lallas, Mark J Mann, Hanan Goldberg, Thenappan Chandrasekar
INTRODUCTION: Wallis et al (JAMA 2017) demonstrated use of antithrombotic medications (ATMs) is associated with increased prevalence of hematuria-related complications and subsequent bladder cancer diagnosis within 6 months. Stage of diagnosis was lacking in this highly publicized study. This study examined the association of ATM use on bladder cancer stage at the time of diagnosis. MATERIALS AND METHODS: We completed a retrospective chart review of patients with a bladder cancer diagnosis at our institution...
December 2022: Canadian Journal of Urology